Preventing perinatal human immunodeficiency virus transmission: Factors influencing women's intentions toward zidovudine therapy

Richard L. Sowell, Carolyn L Murdaugh, Cheryl Addy, Linda Moneyham, Abbas Tavokoli, Terry Misener

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background. Despite the benefits of zidovudine (ZDV) therapy in preventing perinatal transmission of the human immunodeficiency virus, HIV-infected women may not accept or adhere to therapy. Methods. This descriptive study identified factors in 322 HIV-infected women that influence intention to take ZDV if becoming pregnant and to give it to their newborns. Results. Logistic regression analysis showed the likelihood of taking ZDV in pregnancy and giving it to newborns was greater in women who believed ZDV slowed disease progression, ZDV was effective in preventing perinatal transmission, and their primary health care provider (PHCP) was positive about ZDV therapy. Additionally, women who were sexually active and had been pregnant since HIV diagnosis were more likely to intend to give ZDV to newborns. Conclusions. Positive beliefs concerning ZDV effectiveness and the perception that their PHCP has a positive view of ZDV therapy during pregnancy are significant factors in women's ZDV-related decisions.

Original languageEnglish (US)
Pages (from-to)1177-1184
Number of pages8
JournalSouthern Medical Journal
Volume94
Issue number12
StatePublished - 2001
Externally publishedYes

Fingerprint

Zidovudine
HIV
Therapeutics
Newborn Infant
Health Personnel
Primary Health Care
Pregnancy
Disease Progression
Logistic Models
Regression Analysis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Preventing perinatal human immunodeficiency virus transmission : Factors influencing women's intentions toward zidovudine therapy. / Sowell, Richard L.; Murdaugh, Carolyn L; Addy, Cheryl; Moneyham, Linda; Tavokoli, Abbas; Misener, Terry.

In: Southern Medical Journal, Vol. 94, No. 12, 2001, p. 1177-1184.

Research output: Contribution to journalArticle

Sowell, Richard L. ; Murdaugh, Carolyn L ; Addy, Cheryl ; Moneyham, Linda ; Tavokoli, Abbas ; Misener, Terry. / Preventing perinatal human immunodeficiency virus transmission : Factors influencing women's intentions toward zidovudine therapy. In: Southern Medical Journal. 2001 ; Vol. 94, No. 12. pp. 1177-1184.
@article{d44b751f184743ae83ad7ba6021f5c9e,
title = "Preventing perinatal human immunodeficiency virus transmission: Factors influencing women's intentions toward zidovudine therapy",
abstract = "Background. Despite the benefits of zidovudine (ZDV) therapy in preventing perinatal transmission of the human immunodeficiency virus, HIV-infected women may not accept or adhere to therapy. Methods. This descriptive study identified factors in 322 HIV-infected women that influence intention to take ZDV if becoming pregnant and to give it to their newborns. Results. Logistic regression analysis showed the likelihood of taking ZDV in pregnancy and giving it to newborns was greater in women who believed ZDV slowed disease progression, ZDV was effective in preventing perinatal transmission, and their primary health care provider (PHCP) was positive about ZDV therapy. Additionally, women who were sexually active and had been pregnant since HIV diagnosis were more likely to intend to give ZDV to newborns. Conclusions. Positive beliefs concerning ZDV effectiveness and the perception that their PHCP has a positive view of ZDV therapy during pregnancy are significant factors in women's ZDV-related decisions.",
author = "Sowell, {Richard L.} and Murdaugh, {Carolyn L} and Cheryl Addy and Linda Moneyham and Abbas Tavokoli and Terry Misener",
year = "2001",
language = "English (US)",
volume = "94",
pages = "1177--1184",
journal = "Southern Medical Journal",
issn = "0038-4348",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Preventing perinatal human immunodeficiency virus transmission

T2 - Factors influencing women's intentions toward zidovudine therapy

AU - Sowell, Richard L.

AU - Murdaugh, Carolyn L

AU - Addy, Cheryl

AU - Moneyham, Linda

AU - Tavokoli, Abbas

AU - Misener, Terry

PY - 2001

Y1 - 2001

N2 - Background. Despite the benefits of zidovudine (ZDV) therapy in preventing perinatal transmission of the human immunodeficiency virus, HIV-infected women may not accept or adhere to therapy. Methods. This descriptive study identified factors in 322 HIV-infected women that influence intention to take ZDV if becoming pregnant and to give it to their newborns. Results. Logistic regression analysis showed the likelihood of taking ZDV in pregnancy and giving it to newborns was greater in women who believed ZDV slowed disease progression, ZDV was effective in preventing perinatal transmission, and their primary health care provider (PHCP) was positive about ZDV therapy. Additionally, women who were sexually active and had been pregnant since HIV diagnosis were more likely to intend to give ZDV to newborns. Conclusions. Positive beliefs concerning ZDV effectiveness and the perception that their PHCP has a positive view of ZDV therapy during pregnancy are significant factors in women's ZDV-related decisions.

AB - Background. Despite the benefits of zidovudine (ZDV) therapy in preventing perinatal transmission of the human immunodeficiency virus, HIV-infected women may not accept or adhere to therapy. Methods. This descriptive study identified factors in 322 HIV-infected women that influence intention to take ZDV if becoming pregnant and to give it to their newborns. Results. Logistic regression analysis showed the likelihood of taking ZDV in pregnancy and giving it to newborns was greater in women who believed ZDV slowed disease progression, ZDV was effective in preventing perinatal transmission, and their primary health care provider (PHCP) was positive about ZDV therapy. Additionally, women who were sexually active and had been pregnant since HIV diagnosis were more likely to intend to give ZDV to newborns. Conclusions. Positive beliefs concerning ZDV effectiveness and the perception that their PHCP has a positive view of ZDV therapy during pregnancy are significant factors in women's ZDV-related decisions.

UR - http://www.scopus.com/inward/record.url?scp=0035696370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035696370&partnerID=8YFLogxK

M3 - Article

C2 - 11811856

AN - SCOPUS:0035696370

VL - 94

SP - 1177

EP - 1184

JO - Southern Medical Journal

JF - Southern Medical Journal

SN - 0038-4348

IS - 12

ER -